Skip to main content
. 2014 Apr 27;13:73. doi: 10.1186/1476-511X-13-73

Table 2.

Baseline laboratory characteristics according to cut-off value of serum Triglycerides in the study population

Variables
Total
         Fasting triglycerides
P-value
    <1.2 mmol/L (N = 103) ≥2 mmol/L (N = 226)  
Biochemical markers
 
 
 
 
  hs-CRP (mg/L)
3.2 ± 4.1
3.5 ± 4.5
3.1 ± 3.9
0.440
  Leucocyte count (109/L)
6.5 ± 1.6
6.2 ± 1.5
6.6 ± 1.6
0.048
  Neutrophil count (109/L)
3.8 ± 1.2
3.6 ± 1.1
3.9 ± 1.2
0.041
  Neutrophil/lymphocyte ratio
2.2 ± 1.1
2.1 ± 1.0
2.2 ± 1.1
0.530
  Fasting blood glucose (mmol/L)
6.1 ± 2.2
5.7 ± 1.9
6.3 ± 2.3
0.025
  Hemoglobin A1C (%)
6.9 ± 1.4
6.7 ± 1.3
6.9 ± 1.4
0.149
  D-dimer (ug/mL)
0.4 ± 0.5
0.4 ± 0.6
0.4 ± 0.4
0.252
  Fibrinogen (g/L)
3.1 ± 0.8
3.1 ± 0.8
3.1 ± 0.9
0.644
  Endothelin-1 (fmol/ml)
0.6 ± 0.3
0.6 ± 0.3
0.6 ± 0.3
0.587
  Alkaline phosphatase (IU/L)
63.5 ± 18.6
62.0 ± 20.1
64.2 ± 17.9
0.318
  Uric acid (mmol/L)
338.3 ± 78.9
314.9 ± 75.9
348.9 ± 78.1
0.000
  Creatinine (umol/L)
76.3 ± 15.6
74. 4 ± 14.0
77.2 ± 16.2
0.138
Lipid profile
 
 
 
 
  Total cholesterol (mmol/L)
4.0 ± 1.0
3.5 ± 0.8
4.2 ± 1.1
0.000
  LDL-C (mmol/L)
2.4 ± 0.9
2.1 ± 0.7
2.5 ± 0.9
0.000
  HDL-C (mmol/L)
1.1 ± 0.3
1.1 ± 0.3
1.0 ± 0.3
0.002
  Lipoprotein (a) (mg/L)
244.4 ± 244.5
267.9 ± 218.9
233.6 ± 254.9
0.237
  apoA(g/L)
1.4 ± 0.3
1.4 ± 0.3
1.4 ± 0.3
0.477
  apoB(g/L)
1.0 ± 0.3
0.9 ± 0.2
1.1 ± 0.3
0.000
  TG/HDL-C index
1.7 ± 1.3
0.8 ± 0.3
2.2 ± 1.3
0.000
  Non-HDL-C (mmol/L)
2.9 ± 0.9
2.4 ± 0.7
3.1 ± 0.9
0.000
  LDL-C/HDL-C ratio 2.3 ± 0.8 1.9 ± 0.7 2.4 ± 0.8 0.000

hs-CRP high sensitivity C-reactive protein, LDL-C Low density lipoprotein cholesterol, HDL-C High density lipoprotein cholesterol, Non-HDL-C Non-High density lipoprotein cholesterol = Total cholesterol subtracts to high density lipoprotein cholesterol, TG/HDL-C index Triglycerides/high density lipoprotein cholesterol ratio, LDL-C/HDL-C ratio Low density lipoprotein cholesterol/High density lipoprotein cholesterol ratio.